• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Conferences

Conferences

Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering

September 17, 2019 | Discovery on target

Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering

Luke Robinson

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Schaefers, et. al.

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

Kristi Schaefers, Kristin Narayan, Susan Sloan, David Oldach, other authors

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Narayan, et. al.

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

Kristin Narayan, Jeremy Jones, Scott Rich, Elena Govorkova, Susan Sloan, David Oldach

>SEE POSTER

Designing and Engineering Antibodies to Mutable Protein Targets

April 14, 2019 | World Vaccine Congress

Designing and Engineering Antibodies to Mutable Protein Targets

Greg Babcock

Pharmacophore-based Protein Surface Patch Searching and Its Application to in silico Antibody Engineering

April 11, 2019 | PEGS
Bohnuud, et. al.

Pharmacophore-based Protein Surface Patch Searching and Its Application to in silico Antibody Engineering

Tanggis Bohnuud, Andrew Wollacott, Karthik Viswanathan

>SEE POSTER

Antibody Design and Engineering Through Integration of Computational and Experimental Methods

February 26, 2019 | Antibody Engineering & Therapeutics, Asia

Antibody Design and Engineering Through Integration of Computational and Experimental Methods

Karthik Viswanathan

Improved Computational Modeling of Antibody-Antigen Complexes by Integration of Deep Mutational Scanning Data

January 15, 2019 | Peptalk

Improved Computational Modeling of Antibody-Antigen Complexes by Integration of Deep Mutational Scanning Data

Andrew Wollacott

Structure Guided Optimization of Antibody Fc and Fab Domains for Improved Pharmacokinetic Properties

January 15, 2019 | Peptalk
Booth, et. al.

Structure Guided Optimization of Antibody Fc and Fab Domains for Improved Pharmacokinetic Properties

Brain J Booth, Boopathy Ramakrishnan, Kristin Narayan, Andrew M Wollacott, Danielle Wisheart, Alison Thomson, Brianna Close, Gregory J Babcock, Zachary Shriver and Karthik Viswanathan

>SEE POSTER

(Sibeprenlimab), an APRIL-Neutralizing IgG2

November 13, 2018 | International Society for Influenza and Respiratory Viruses (ISIRV) Antiviral Drug Development Conference
Hershberger, et. al.

(Sibeprenlimab), an APRIL-Neutralizing IgG2

Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine Hay, Patrick Smith, Frank Engler, Jose Trevejo, Zach Shriver, David Oldach

Monoclonal Antibody, in Healthy Volunteers

November 13, 2018 | International Society for Influenza and Respiratory Viruses (ISIRV) Antiviral Drug Development Conference
Narayan, et. al.

Monoclonal Antibody, in Healthy Volunteers

Kristin Narayan, Bharathi Sundaresh, Emily Helger, Andrew Wollacott, Karthik Viswanathan, Gregory Babcock, David Oldach, Susan Sloan

  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design